Initiatives to eradicate malaria have a good impact on P. falciparum malaria worldwide. P.
vivax, however, still presents significant difficulties. This is due to its unique biological traits …

Extensive research has examined why some people have frequent Plasmodium falciparum
malaria episodes in sub-Saharan Africa while others remain free of disease most of the time …

Background The increase in detections of Plasmodium vivax infection in Duffy-negative
individuals in Africa has challenged the dogma establishing the unique P. vivax Duffy …

The 1990s saw the rapid reemergence of malaria in Amazonia, where it remains an
important public health priority in South America. The Amazonian International Center of …

Although the power of genetic surveillance tools has been acknowledged widely, there is an
urgent need in malaria endemic countries for feasible and cost-effective tools to implement …

Pathogen genomic epidemiology has the potential to provide a deep understanding of
population dynamics, facilitating strategic planning of interventions, monitoring their impact …

Background Plasmodium vivax malaria is challenging to control and eliminate. Treatment
with radical cure drugs fails to target the hidden asymptomatic and hypnozoite reservoirs in …

Background Plasmodium vivax malaria is now recognized as a cause of severe morbidity
and mortality, resulting in a substantial negative effect on health especially in endemic …

Background The vector species in the Amazon River Basin are regionally and locally
diverse, which makes it imperative to understand and compare their roles in malaria …

Introduction Plasmodium vivax malaria causes significant disease burden worldwide,
especially in Latin America, Southeast Asia, and Oceania. P. vivax is characterized by the …